Introduction
The stock market is buzzing with fresh recommendations from top brokerages like Motilal Oswal, Nuvama, Anand Rathi, and Prabhudas Lilladher. These firms have initiated coverage on 8 high-potential stocks, including:
✔ Suzlon Energy (Renewables)
✔ PCBL (Carbon Black)
✔ Waaree Energies (Solar & Green Hydrogen)
✔ DMART (Retail)
✔ Union Bank of India (Banking)
✔ Laxmi Dental (Healthcare)
✔ Dr. Agarwals Health Care (Eye Care)
✔ Unimech Aerospace (Defense & Aerospace)
In this article, we break down:
✅ Brokerage ratings & price targets
✅ Growth potential of each stock
✅ Key risks to watch
✅ Should you invest now?
1. Motilal Oswal Recommends Suzlon Energy (Target: ₹70, 22% Upside)
Why Suzlon?
- Largest wind energy player in India (20.9 GW installed capacity).
- Strong order book (3.2 GW expected by FY27).
- Revenue growth forecast: 51% CAGR (FY24-27).
Key Risks:
- Policy changes in renewable energy subsidies.
- Execution delays in project deliveries.
Verdict: A good bet on India’s renewable energy push.
2. Prabhudas Lilladher Bullish on PCBL (Target: ₹543, 30% Upside)
Why PCBL?
- India’s largest carbon black manufacturer (7th globally).
- Expanding capacity to 1 million tonnes by FY28.
- Rising specialty-grade contribution (higher margins).
Key Risks:
- Raw material price volatility (crude oil-linked).
- Global competition from Chinese players.
Verdict: Strong growth in specialty carbon black makes it a buy.
3. Nuvama’s Top Pick: Waaree Energies (Target: ₹2,805, 15% Upside)
Why Waaree?
- Solar + Green Hydrogen focus (multi-decade opportunity).
- Revenue CAGR of 30% (FY24-27).
- New cell plant to boost EBITDA by ₹2,000 crore in FY26.
Key Risks:
- High valuation (early-stage growth premium).
- Regulatory risks in renewable energy policies.
Verdict: High-risk, high-reward play on India’s green energy shift.
4. Anand Rathi on Unimech Aerospace (Target: ₹1,315, 35% Upside)
Why Unimech?
- Specializes in aerospace & defense components.
- Expanding into nuclear energy & high-precision manufacturing.
- Strong OEM partnerships (long-term contracts).
Key Risks:
- Dependence on government defense spending.
- Execution risks in new segments.
Verdict: A solid pick for defense & aerospace growth.
5. Union Bank of India: Prabhudas Lilladher’s Buy (Target: ₹140, 17% Upside)
Why Union Bank?
- Declining NPAs (GNPA down to 3.9%).
- Stable NIMs & improving fee income.
- Attractive valuation (P/B of 0.9x).
Key Risks:
- Slow deposit growth vs. credit demand.
- Competition from private banks.
Verdict: A good public sector bank bet for steady returns.
6. Laxmi Dental: Nuvama’s Hidden Gem (Target: ₹570, 38% Upside)
Why Laxmi Dental?
- Only fully-integrated dental company in India.
- 22,000+ dental clinics network.
- Revenue CAGR of 26% (FY25-28E).
Key Risks:
- Low brand awareness vs. global players.
- Regulatory hurdles in medical devices.
Verdict: High-growth potential in underpenetrated dental market.
7. Dr. Agarwals Health Care: Motilal Oswal’s Eye Care Bet (Target: ₹510, 18% Upside)
Why Dr. Agarwals?
- Largest eye care chain in India (hub-and-spoke model).
- Adding 40-50 clinics/year.
- Strong brand in ophthalmology.
Key Risks:
- High expansion costs.
- Competition from hospitals.
Verdict: A steady healthcare stock with scalability.
8. DMART: Anand Rathi’s ‘Hold’ (Target: ₹4,254, 6% Upside)
Why DMART?
- Leader in organized retail (EDLC/EDLP model).
- Debt-free with strong cash flows.
- Expanding into e-commerce.
Key Risks:
- Slow store expansion.
- Competition from Reliance & online grocers.
Verdict: A safe hold, but limited upside.
Final Verdict: Which Stocks Should You Buy?
| Stock | Brokerage | Rating | Target (Upside) | Risk Level |
|---|---|---|---|---|
| Suzlon | Motilal Oswal | Buy | ₹70 (22%) | Medium-High |
| PCBL | Prabhudas | Buy | ₹543 (30%) | Medium |
| Waaree | Nuvama | Buy | ₹2,805 (15%) | High |
| Unimech | Anand Rathi | Buy | ₹1,315 (35%) | Medium |
| Union Bank | Prabhudas | Buy | ₹140 (17%) | Low-Medium |
| Laxmi Dental | Nuvama | Buy | ₹570 (38%) | High |
| Dr. Agarwals | Motilal Oswal | Buy | ₹510 (18%) | Medium |
| DMART | Anand Rathi | Hold | ₹4,254 (6%) | Low |
Best Picks for 2025-26:
- High Growth: Waaree, Unimech, Laxmi Dental
- Steady Returns: PCBL, Union Bank, Dr. Agarwals
- Wait & Watch: DMART
Conclusion
Brokerages are betting big on renewables (Suzlon, Waaree), specialty chemicals (PCBL), and niche sectors (Unimech, Laxmi Dental). While some stocks offer high upside (35-38%), others like DMART are stable but limited in growth.
Before investing:
✔ Check quarterly results
✔ Monitor sector trends
✔ Diversify your portfolio
Which of these stocks are you considering? Let us know in the comments!